Tatiana Prowell, M.D.
Breast Cancer Scientific Lead, Office of Hematology and Oncology Products
U.S. Food and Drug Administration
Dr. Prowell received her B.A. in English from Bard College and her M.D. from the Johns Hopkins University School of Medicine with election to Phi Beta Kappa Honor Society and Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine in the Osler Housestaff Training Program and a fellowship in medical oncology in the Breast Cancer Research Program, both at Johns Hopkins Hospital.
Dr. Prowell has received the American Society of Clinical Oncology Young Investigator Award and twice received the Pearl M. Stetler Research Fund for Women Award for her breast cancer research. In 2006, she joined the U.S. Food and Drug Administration where she currently serves as Breast Cancer Scientific Lead within the Office of Hematology and Oncology Products. She has recently helped to pioneer use of pathological complete response as a novel endpoint for accelerated approval of agents to treat high-risk, early-stage breast cancer.
Dr. Prowell is an assistant professor of oncology at The Johns Hopkins University School of Medicine and sees patients in the second opinion breast cancer clinic at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.